DexCom, Inc. (LON:0A4M)
London flag London · Delayed Price · Currency is GBP · Price in USD
81.67
0.00 (0.00%)
At close: Aug 21, 2025

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of GBP 21.79 billion. The enterprise value is 21.53 billion.

Market Cap21.79B
Enterprise Value 21.53B

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date Oct 23, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 392.16M
Shares Outstanding n/a
Shares Change (YoY) -2.97%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 389.51M

Valuation Ratios

The trailing PE ratio is 52.25 and the forward PE ratio is 31.33.

PE Ratio 52.25
Forward PE 31.33
PS Ratio 6.94
PB Ratio 11.60
P/TBV Ratio 12.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.33, with an EV/FCF ratio of 51.69.

EV / Earnings 51.62
EV / Sales 6.76
EV / EBITDA 30.33
EV / EBIT 42.34
EV / FCF 51.69

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 1.00.

Current Ratio 1.52
Quick Ratio 1.30
Debt / Equity 1.00
Debt / EBITDA 2.69
Debt / FCF 4.52
Interest Coverage 36.17

Financial Efficiency

Return on equity (ROE) is 22.83% and return on invested capital (ROIC) is 8.44%.

Return on Equity (ROE) 22.83%
Return on Assets (ROA) 6.08%
Return on Invested Capital (ROIC) 8.44%
Return on Capital Employed (ROCE) 17.10%
Revenue Per Employee 306,259
Profits Per Employee 40,696
Employee Count10,300
Asset Turnover 0.61
Inventory Turnover 3.05

Taxes

In the past 12 months, DexCom has paid 155.18 million in taxes.

Income Tax 155.18M
Effective Tax Rate 27.11%

Stock Price Statistics

The stock price has increased by +11.74% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +11.74%
50-Day Moving Average 80.49
200-Day Moving Average 86.86
Relative Strength Index (RSI) 52.05
Average Volume (20 Days) 6,735

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.77

Income Statement

In the last 12 months, DexCom had revenue of GBP 3.14 billion and earned 417.14 million in profits. Earnings per share was 1.04.

Revenue3.14B
Gross Profit 1.84B
Operating Income 501.59M
Pretax Income 572.31M
Net Income 417.14M
EBITDA 673.92M
EBIT 501.59M
Earnings Per Share (EPS) 1.04
Full Income Statement

Balance Sheet

The company has 2.14 billion in cash and 1.88 billion in debt, giving a net cash position of 255.47 million.

Cash & Cash Equivalents 2.14B
Total Debt 1.88B
Net Cash 255.47M
Net Cash Per Share n/a
Equity (Book Value) 1.88B
Book Value Per Share 4.79
Working Capital 1.26B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 720.92 million and capital expenditures -304.30 million, giving a free cash flow of 416.63 million.

Operating Cash Flow 720.92M
Capital Expenditures -304.30M
Free Cash Flow 416.63M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 58.77%, with operating and profit margins of 15.98% and 13.29%.

Gross Margin 58.77%
Operating Margin 15.98%
Pretax Margin 18.23%
Profit Margin 13.29%
EBITDA Margin 21.47%
EBIT Margin 15.98%
FCF Margin 13.27%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 2.97%
Shareholder Yield n/a
Earnings Yield 1.91%
FCF Yield 1.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date Jun 13, 2022
Split Type Forward
Split Ratio 4

Scores

DexCom has an Altman Z-Score of 5.47 and a Piotroski F-Score of 6.

Altman Z-Score 5.47
Piotroski F-Score 6